MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation
Graphical abstract
Introduction
UHMWPE wear-induced osteolysis is a complex process during which prosthetic debris released from the surface of prosthetic joints made of wear-producing-material induces an immune response that favors bone catabolism, thereby resulting in the loosening of the prosthesis, fracture, and other failures [1]. Although many factors account for the process, bone resorption mediated by osteoclasts and the self-propagating immune response initiated by mononuclear macrophages are the main effectors. Schmalzried et al. examined histological samples derived from areas of bone resorption from patients with radiographic evidence of periprosthetic osteolysis and detected polyethylene debris-laden macrophages [2]. Further evidence confirmed the involvement of UHMWPE wear particles in aseptic inflammation [3]. For instance, particulates with diameters of 0.1–1.0 μm can be phagocytosed by macrophages and are the most biologically active, triggering TNF-α, IL-6, IL-1β, and prostaglandin E2 (PGE2) production and causing local infiltration, which promotes osteoclastogenesis and bone resorption and disturbs bone metabolism by inducing RANKL secretion and suppressing that of its decoy, OPG [[4], [5], [6]]. Therefore, studies on therapeutic agents for osteolysis focus on those utilized in catabolic bone diseases such as bisphosphonates [7], TNF-α antagonists, IL-1β antagonists [8], IL-10, OPG vectors [9], and the recently approved monoclonal antibody against RANKL, denosumab [10]. However, none of these compounds can simultaneously block both the main effects of wear debris and the side effects form barriers to a wider use [11]. Here, we identify an mtDNA-encoded peptide, MOTS-c, that can alleviate inflammation and bone resorption in a commonly utilized osteolysis model induced by UHMWPE particles [12] and report that it may be a potential drug for aseptic loosening.
MOTS-c, a mitochondrial-encoded peptide, has been characterized as a 16-amino acid peptide with multiple roles in cell metabolism and Lee et al. first identified the peptide, which was encoded in short open reading frames within the mitochondrial genome, and showed that it promoted metabolic homeostasis and reduced insulin resistance [13]. Kim et al. discovered that the peptide dynamically translocated to the nucleus in response to metabolic stress, where it regulated the expression of nuclear genes [14]. Recently, several studies on the peptide have revealed its role in adipose homeostasis, infectious disease, and endothelial dysfunction [[15], [16], [17]]. However, it is not known whether MOTS-c can affect immune cells during aseptic inflammation. In search of novel drugs for aseptic loosening with fewer side effects and better therapeutic outcomes, we set out to explore the anti-inflammatory effects and bone-protective properties of MOTS-c and to define the mechanism of its anti-inflammatory effects.
Section snippets
Cell culture and animal experiment
Dulbecco’s modified Eagle medium (Gibco, USA) supplemented with 10% fetal bovine serum (Gibco, USA), penicillin (100 U/mL, Gibco), and streptomycin (100 mg/ml) (Gibco) was used to culture primary mouse bone marrow macrophages (BMMs) and primary mouse osteocytes. Cells were obtained as previously described [18]. Osteocytes were obtained from mouse calvaria cultured in osteogenic medium supplemented with 1 nM dexamethasone, 50 μM ascorbic acid-2-phosphate and 20 mM β-glycerophosphate
MOTS-c protects bone mass and alleviates inflammation in UHMWPE particle-induced osteolysis
To validate the effects of MOTS-c on UHMWPE particle-induced osteolysis, we conducted experiments using an osteolysis mouse model as previously described [19]. Briefly, UHMWPE particles were used to simulate periprosthetic aseptic inflammation in vivo. We then evaluated bone mass in different groups with micro-CT scanning. The micro-CT scanning results confirmed UHMWPE particle-induced bone erosion, and multiple bone defects were detected in the control group treated with the UHMWPE particles.
Discussion
According to one study on primary total hip arthroplasties (THA), one of the most common causes for total hip revision surgery is aseptic loosening [41]. Aseptic loosening by periprosthetic osteolysis is the leading cause of failure after total joint arthroplasty (TJA), with the reported incidence rate ranging from 10% to 70% and the incidence of TJA still increasing [[42], [43]]. Wear particles cause inflammation and osteolysis, thereby leading to continuous synovitis which causes pain,
Conclusion
In conclusion, considering its constitutive role in mitochondrial protein expression, our current data suggest that MOTS-c has a potent anti-inflammatory effect in osteolysis therapy with fewer side effects, and it holds promise in anti-inflammatory therapy in the future.
Ethics statement
This study was carried out in accordance with the recommendations of the Laboratory Animal Center of Fourth Military Medical University (permit no. 20161003).
CRediT authorship contribution statement
Zhao Yan: Experiment design, Writing - review & editing. Shu Zhu: Data analysis, Investigation. Hanli Wang: Methodology, Investigation. Li Wang: Conceptualization, Investigation. Tianshu Du: Investigation. Zichen Ye: Investigation. Dongsheng Zhai: Investigation. Zheng Zhu: Data analysis. Xiaoxi Tian: Funding acquisition. Zifan Lu: Funding acquisition, Experiment design. Xiaorui Cao: Project administration, Funding acquisition.
Declaration of Competing Interest
The authors declare that they have no conflict of interest.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81501936), (31571215) and (81802168).
References (75)
- et al.
Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis
BIOMATERIALS
(2017) - et al.
Wear debris from bipolar femoral neck-cup impingement. A cause of femoral stem loosening
J ARTHROPLASTY
(1994) - et al.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
CELL METAB
(2015) - et al.
MOTS-c peptide increases survival and decreases bacterial load in mice infected with MRSA
MOL IMMUNOL
(2017) - et al.
Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation
Biochem Biophys Res Commun
(2016) - et al.
Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis
INT IMMUNOPHARMACOL
(2018) - et al.
Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells
J BIOL CHEM
(1998) - et al.
Regulation of osteoclast activity in peri-implant tissues
BIOMATERIALS
(2004) - et al.
Mitochondrial ROS signaling in organismal homeostasis
CELL
(2015) - et al.
PGC-1 alpha serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy
J BIOL CHEM
(2010)
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
CELL METAB
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
CELL
Hip replacement
LANCET
Hip arthroplasty
LANCET
Knee replacement
LANCET
Polyethylene particles in joint fluid and osteolysis in revision total knee arthroplasty
KNEE
Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening
BONE
Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide
BIOMATERIALS
MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism
Free Radic Biol Med
A mitochondrially encoded hormone ameliorates obesity and insulin resistance
CELL METAB
Association between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivo
BIOMATERIALS
NF-kappaB activation by reactive oxygen species: fifteen years later
BIOCHEM PHARMACOL
Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network
Biochim Biophys Acta
PGC-1 coactivators and skeletal muscle adaptations in health and disease
CURR OPIN GENET DEV
Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha as a Novel Target for Bipolar Disorder and Other Neuropsychiatric Disorders
Biol Psychiatry
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
CELL
AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species
CELL REP
Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space
J BONE JOINT SURG AM
Morphological characteristics of total joint arthroplasty-derived ultra-high molecular weight polyethylene (UHMWPE) wear debris that provoke inflammation in a murine model of inflammation
J BIOMED MATER RES A
Macrophage reactivity to different polymers demonstrates particle size- and material-specific reactivity: PEEK-OPTIMA((R)) particles versus UHMWPE particles in the submicron, micron, and 10 micron size ranges
J Biomed Mater Res B Appl Biomater
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis
J BIOMED MATER RES A
Effect of bisphosphonates on periprosthetic bone loss after total knee arthroplasty: a meta-analysis of randomized controlled trials
BMC Musculoskelet Disord
Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysis
GENE THER
Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model
Arthritis Rheum
Denosumab for treating periprosthetic osteolysis; study protocol for a randomized, double-blind, placebo-controlled trial
BMC Musculoskelet Disord
Atypical fractures as a potential complication of long-term bisphosphonate therapy
JAMA
Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis
J ORTHOP RES
Cited by (38)
MOTS-c: A potential anti-pulmonary fibrosis factor derived by mitochondria
2023, MitochondrionOxidative stress: A common pathological state in a high-risk population for osteoporosis
2023, Biomedicine and PharmacotherapyOrally administered MOTS-c analogue ameliorates dextran sulfate sodium-induced colitis by inhibiting inflammation and apoptosis
2023, European Journal of PharmacologyCitation Excerpt :A growing body of evidence suggests that MOTS-c regulates insulin and metabolic homeostasis via the folate-purine-AMPK pathway (Kim et al., 2018; Lee et al., 2015; Ming et al., 2016; Reynolds et al., 2021). Numerous reports also indicate that MOTS-c exerts anti-inflammatory and anti-apoptotic effects through the AMPK signaling pathway (Yan et al., 2019; Zhai et al., 2017). Our previous report showed that MOTS-c attenuates amyloid β (Aβ1-42)- or LPS-induced memory impairment via AMPK activation (Jiang et al., 2021).
The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus
2022, Pharmacological ResearchCitation Excerpt :It was reported that pancreatic islet inflammatory lesions are an important cause of STZ-induced diabetes mellitus [29]. MOTS-c has been shown to have the ability to inhibit inflammation in several studies [30–32], which highlights new ways to investigate the mechanism of MOTS-c. Poor productive outcomes, including macrosomia, high death rates of offspring, birth injury and neonatal hypoglycemia, are other major adverse symptoms of GDM [5].
Mitochondrial-encoded MOTS-c prevents pancreatic islet destruction in autoimmune diabetes
2021, Cell ReportsCitation Excerpt :Future studies are needed to identify markers for different types of Treg cells to analyze the function of MOTS-c. MOTS-c treatment increased serum IL-10 in NOD mice and in other mouse models (Xinqiang et al., 2020; Yan et al., 2019; Yin et al., 2020; Zhai et al., 2017). Together with the fact that IL-10 is a potent anti-inflammatory cytokine associated with T1D prevention (Nitta et al., 1998; Zheng et al., 1997), it is likely that MOTS-c-induced IL-10 may act as a mediator.
- 1
These authors have contributed equally to this work.